Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics

被引：8
|
作者：
Renner, Andreas [1 ,3 ,4 ]
Marth, Katharina [1 ]
Patocka, Karin [1 ]
Idzko, Marco [2 ]
Pohl, Wolfgang [1 ]
机构：
[1] Hietzing Hosp, Karl Landsteiner Inst Clin & Expt Pneumol, Wolkersbergenstr 1, A-1130 Vienna, Austria
[2] Med Univ Vienna, Dept Pulmonol, Vienna, Austria
[3] Univ Helsinki, Fac Med, Individualized Drug Therapy Res Program, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
来源：
ALLERGY | 2020年 / 75卷 / 12期
关键词：
D O I：
10.1111/all.14441
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3272 / 3275
页数：4
相关论文
共 50 条
  • [1] REAL-LIFE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA WITH BENRALIZUMAB
    Pelaia, C.
    Busceti, M. T.
    Vatrella, A.
    Rago, G. F.
    Crimi, C.
    Pelaia, G.
    [J]. CHEST, 2020, 157 (06) : 6A - 6A
  • [2] Benralizumab is effective in Austrian severe eosinophilic asthma patients: preliminary real-life data
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Pohl, Wolfgang
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 (19-20) : 516 - 516
  • [3] Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study
    Renner, Andreas
    Marth, Katharina
    Patocka, Karin
    Pohl, Wolfgang
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
    Chan, Rory
    Lipworth, Brian J.
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [5] Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
    Scioscia, Giulia
    Tondo, Pasquale
    Nolasco, Santi
    Pelaia, Corrado
    Carpagnano, Giovanna Elisiana
    Caiaffa, Maria Filomena
    Valenti, Giuseppe
    Maglio, Angelantonio
    Papia, Francesco
    Triggiani, Massimo
    Crimi, Nunzio
    Pelaia, Girolamo
    Vatrella, Alessandro
    Barbaro, Maria Pia Foschino
    Crimi, Claudia
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [6] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Nishioka, Saiko
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [7] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Takanori Numata
    Hanae Miyagawa
    Saiko Nishioka
    Keitaro Okuda
    Hirofumi Utsumi
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    [J]. BMC Pulmonary Medicine, 20
  • [8] Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] A real-life comparison of patients with severe eosinophilic asthma treated with benralizumab or mepolizumab
    Andersen, Helle H.
    Smidt-Hansen, Torben
    Pedersen, Lene M.
    Skjold, Tina
    Schmid, Johannes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab
    Menzella, Francesco
    Aliani, Maria
    Altieri, Elena
    Bracciale, Pietro
    Centanni, Stefano
    De Michele, Fausto
    Di Marco, Fabiano
    Pelaia, Girolamo
    Romagnoli, Micaela
    Schino, Pietro
    Boarino, Silvia
    Vitiello, Gianfranco
    Rogliani, Paola
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345